Co-prescribing of Central Nervous System-Active Medications for COPD Patients: Impact on Emergency Room Visits and Hospitalization.
Akhil SoodYong-Fang KuoJordan WestraGulshan SharmaMukaila A RajiPublished in: The Annals of pharmacotherapy (2022)
Opioids in combination with GABA and SSRI/SNRI demonstrate relatively lower risk for acute respiratory events among patients with COPD and comorbid chronic pain and anxiety. The findings emphasize the need for multimodal management in this vulnerable population.
Keyphrases
- chronic pain
- chronic obstructive pulmonary disease
- pain management
- end stage renal disease
- lung function
- ejection fraction
- newly diagnosed
- primary care
- emergency department
- public health
- prognostic factors
- respiratory failure
- drug induced
- patient reported outcomes
- cystic fibrosis
- physical activity
- adverse drug
- emergency medical